×

Equipment and Services Health Care Equipment and Supplies

  • LONDON, Sept 13- Sophia Genetics, a data-driven healthcare company backed by British entrepreneur Mike Lynch, has raised $30 million in a funding round led by Balderton Capital to further develop its technology. Switzerland- based Sophia said its platform was now being used by 334 hospitals across 53 countries, and had tested more than 125,000 patients to date.

  • Sept 11- Medical device maker Medtronic Plc said on Monday it would recall certain infusion sets used with its insulin pumps by diabetes patients due to a component that could cause death in extreme cases. Infusion sets help connect an insulin pump device to the body. The Dublin- based company received reports of hypoglycemia requiring medical intervention,...

  • Sept 11- Medtronic Plc on Monday said that it would recall certain infusion sets used with all its insulin pumps due to a discontinued component.

  • Sept 5- Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc in its second billion-dollar deal in the past nine months, to strengthen its portfolio of urology devices. Teleflex, which also makes emergency care, respiratory and cardiac devices, said the deal's value could rise to $1.1 billion based on sales of NeoTract's sole...

  • Sept 5- Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc to strengthen its portfolio of urology devices in its second billion-dollar deal in the past nine months. The company's revenue is expected to be between $115 million and $120 million this year, compared with about $51 million in 2016, and is estimated to increase...

  • Sept 5- Medical device maker Teleflex Inc said on Tuesday it would buy privately-held NeoTract Inc in a deal valued at up to $1.1 billion to strengthen its portfolio of urology devices. The company's devices are used in urology, cardiac, respiratory and emergency care, and in December last year it strengthened its coronary and vascular business with the $1...

  • NEW YORK, Aug 29- Abbott Laboratories said on Tuesday it would issue updates to reduce the risk of its St. Jude recalled some of its 400,000 implanted heart devices last October due to risk of premature battery depletion, which was linked to two deaths in Europe. The U.S. Food and Drug Administration said then that hospitals should return unused devices and warned...

  • NEW YORK, Aug 29- Abbott Laboratories said on Tuesday it will issue updates to reduce the risk of its St. Jude recalled some of its 400,000 implanted heart devices last October due to risk of premature battery depletion, which was linked to two deaths in Europe. The U.S. Food and Drug Administration said then that hospitals should return unused devices and warned...

  • NEW YORK, Aug 29- Abbott Laboratories said on Tuesday it will issue updates to reduce the risk of its St. Jude recalled some of its 400,000 implanted heart devices last October due to risk of premature battery depletion, which was linked to two deaths in Europe. The U.S. Food and Drug Administration said then that hospitals should return unused devices and warned...

  • Cramer Remix: Why these US oil fields may be about to make a big market impact

    Jim Cramer has his eyes on an energy asset sale that could make major waves on Wall Street.

  • Jim Cramer on "Mad Money"

    Jim Cramer has his eyes on an energy asset sale that could make major waves on Wall Street.

  • Cardinal Health CEO: How my pharma giant is bucking a difficult environment

    Jim Cramer sat down with George Barrett, the chairman and CEO of Cardinal Health, to see how his health care giant is faring.

  • *1st- qtr rev $7.39 bln vs est $7.45 bln. Shares of the Dublin- based company, which makes heart devices, spinal implants and insulin pumps, dipped as much as 3 percent to $81.00 in morning trading. Sales in Medtronic's diabetes business, which includes artificial pancreas devices and insulin pumps, fell about 1 percent to $449 million in the first quarter ended July...

  • Net income attributable to Medtronic rose to $1.02 billion, or 74 cents per share in the first quarter ended July 28, from $929 million, or 66 cents per share, a year earlier. Net sales climbed 3.1 percent to $7.39 billion. Dublin- based Medtronic generates most of its sales from heart devices, spinal implants and insulin pumps.

  • LONDON, Aug 21- Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch. The company, which listed late last year, said the U.S. Food and Drug Administration had cleared its Speedboat RS2 device...

  • NEW DELHI, Aug 16- India has capped prices of orthopaedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopaedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major international...

  • NEW DELHI, Aug 16- India has capped prices of orthopaedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopaedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies...

  • NEW DELHI, Aug 16- India has capped prices of orthopaedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopaedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies...

  • NEW DELHI, Aug 16- India has capped prices of orthopedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies have...

  • NEW DELHI, Aug 16- India has capped prices of orthopedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies have...